Dr. Venkatesan most recently served as Chairman, President, and CEO of Angion Biomedica until its merger with Elicio Therapeutics in 2023. He currently serves as a Board Director at Elicio ...

BOSTON—Ourania Tatsis, Executive Vice President and Chief Regulatory and Quality Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a $116 billion market cap biotech company currently trading near ...

Singapore government sovereign wealth fund Temasek’s subsidiary, Vertex Ventures, is set to lead a $50-60 million funding ...

AI-driven enterprise tech startup SpotDraft has raised $54 Mn in its Series B funding round led by Vertex Growth and Trident ...

Corporate Venture Capital (CVC) investment is an increasingly used strategic tool that enables large corporations to make minority investments ...

The agreement hands Biogen as much as $250 million in exchange for milestone payments and sales royalties for litifilimab, ...

While bubbles, deception, spin and outright misrepresentation seem to have become the norm in today's startup and VC market, ...

Investors were feeling zen on Wednesday, with no major news about Donald Trump's tariffs to worry about ahead of the monthly ...

One bad year continues to haunt university endowments’ performance. U.S. school funds had a strong fiscal year, rising an average 11.2% in the 12 months through June 30. “Fiscal 2022 is going to stick ...